[ET Net News Agency, 13 November 2025] CSPC PHARMA (01093) rose 3.1% to HK$7.9.
It hits an intra-day high of HK$7.91, and an intra-day low of HK$7.69. The total shares
traded was 26.69 million, with a value of HK$207.91m. The active buy/sell ratio is 60:40,
with net buying turnover of HK$40.8m. MORGAN STANLEY HK SEC accounts for greatest net
responsive buying turnover of HK$11.67m, with volume weighted average price of HK$7.774.
BARCLAYS CAPITAL ASIA accounts for greatest net responsive selling turnover of HK$7.09m,
with volume weighted average price of HK$7.784. The stock has risen a combined 4.5% over
the past 2 consecutive trading days.
The Hang Seng Index now fell 39 points, or 0.1% to 26,883; the Hang Seng China
Enterprises Index now fell 25 points, or 0.3% to 9,513.

Basic Information
=================

----------------------------------
Nominal 7.900 % Chg +3.13%
High 7.910 Low 7.690
Shares Tr 26.69m Turnover 207.91m
10-D SMA 7.573 %H.V 43.425
20-D SMA 7.953 VWAP 7.790
50-D SMA 9.097 RSI14 44.178
----------------------------------
Status: Active buy/sell ratio is 60:40, with net buying turnover of HK$40.8m, rising a
combined 4.5% over the past 2 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
CSPC PHARMA (01093) 7.90 +3.13
SINO BIOPHARM (01177) 7.33 +5.92
HENGRUI PHARMA (01276) 72.15 +0.49
3SBIO (01530) 32.54 +6.13
INNOVENT BIO (01801) 91.40 +4.88
WUXI BIO (02269) 34.22 +2.58
WUXI APPTEC (02359) 103.30 +1.97
HANSOH PHARMA (03692) 37.52 +2.18
BEONE MEDICINES (06160) 227.00 +6.77
AKESO (09926) 120.70 +2.55
-----------------------------------------------
(ed)